A Case-Based Roadmap for Improved Patient Outcomes in Plaque Psoriasis

Released On
August 31, 2021

Expires On
August 31, 2022

Media Type

Completion Time
60 minutes

Dermatology, Education, Pediatrics, Primary Care


Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Annenberg Center for Health Sciences at Eisenhower.

This activity is supported by educational grants from UCB and AbbVie.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hour

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity was developed for dermatologists, primary care physicians, nurse practitioners, physician assistants and other healthcare providers who manage patients with plaque psoriasis.

Program Overview

Plaque psoriasis is a chronic inflammatory skin condition that impacts patient physical, social, and emotional well-being. Join Dr. Steven Feldman in an interactive case-based overview of managing patients with plaque psoriasis. Diagnosis, severity assessment, and treatment are discussed to provide clinicians with a broad overview of optimal plaque psoriasis management. Treatment initiation, switching, and escalation are reviewed, with a focus on common clinical scenarios, such as unplanned treatment interruption and selecting agents for patients who intend to conceive.

Content Areas

  • Pathophysiology
  • Treatment mechanism of action
  • Severity assessment
  • Topical treatment
  • Biologic treatment
  • Treatment switching
  • Comorbidities

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Utilize validated tools to assess plaque psoriasis disease burden and response to treatment
  • Summarize the clinical pharmacology, including mechanism of action, as well as safety and efficacy, of evidence-based medications for plaque psoriasis
  • Apply the results of clinical trials, expert recommendations, and consensus guidelines to develop treatment plans based on patient characteristics, treatment history, and comorbid conditions



Steven R. Feldman, MD, PhD

Professor of Dermatology, Pathology, and Social Sciences & Health Policy
Wake Forest University Health Sciences
Winston-Salem, North Carolina

Physician Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Nursing Credit Designation

A maximum of 1.0 contact hour may be earned for successful completion of this activity.

Disclosures of Conflicts of Interest

Steven R. Feldman, MD, PhD

  • Consultant: AbbVie, Advance Medical, Almirall, Alvotech, Amgen, Arcutis, Arena, BMS, Caremark, Celgene, Dermavant, Galderma Laboratories, LP, Gerson, Lehrman Group, Guidepoint Global, Helsinn, Janssen, Kikaku, Leo Pharma Inc, Lilly, Merck & Co, Inc, Mylan, Novartis Pharmaceuticals Corporation, Ortho Dermatology, Pfizer Inc, Regeneron, Sanofi, Sienna, Sun Pharma, Suncare Research, XenoPort
  • Founder: Causa Technologies
  • Grant Support: AbbVie, Amgen, Celgene, Galderma Laboratories, LP, Janssen, Lilly, Novartis Pharmaceuticals Corporation, Pfizer Inc, Regeneron, Sanofi
  • Royalties: Informa, UpToDate, Xlibris
  • Speakers Bureau: AbbVie, Amgen, Celgene, Janssen, Leo Pharma Inc, Lilly, Novartis Pharmaceuticals Corporation, Ortho Dermatology, Pfizer Inc, Regeneron, Sanofi, Sun Pharma
  • Stockholder: Causa Technologies, Medical Quality Enhancement Corporation

Additional content planners
The following have no significant relationship to disclose

Jessica Martin, PhD (medical writer)
Kam Newman, MD (peer reviewer)
Heather Jimenez, FNP-C (nurse reviewer)

Annenberg Center for Health Sciences
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.
Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved applications.


The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Contact Information

For help or questions about this activity please contact Continuing Education:

Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone 760-773-4500
Fax 760-773-4513
8 am – 5 pm, Pacific Time, Monday – Friday